The Effectiveness of Renal Transplantation as a Treatment for Recurrent Uremic Cardiomyopathy

Canadian Journal of Cardiology - Canada
doi 10.1016/s0828-282x(08)70184-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sodium Potassium Adenosine Triphosphatase (Na/K-ATPase) as a Therapeutic Target for Uremic Cardiomyopathy

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2017English

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation

Kidney Medicine
Internal MedicineNephrology
2019English

Recurrent Hemolytic Uremic Syndrome: A Case Report

International Journal of Contemporary Medical Research [IJCMR]
2018English

The Use of Sofosbuvir for the Treatment of Recurrent Hepatitis C After Liver Transplantation

Transplantologiya
2017English

Nonablative Hematopoietic Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma

Bone Marrow Transplantation
TransplantationHematology
2002English

Transplantation in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2010English

Cirrhotic Cardiomyopathy: Implications for Liver Transplantation

Liver Transplantation
HepatologyTransplantationSurgery
2017English

A Successful Case of Dupilumab Treatment for Severe Uremic Pruritus

JAAD Case Reports
Dermatology
2019English

Effectiveness of Olfactory Ensheathing Cell Transplantation for Treatment of Spinal Cord Injury

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy